Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹18.65
Market cap
₹44.22 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.8×Sector 47.4×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:11 IST BSE
Annual General Meeting

Kabra Drugs Annual General Meeting

Aanjaay Industries Limited announced book closure dates from September 24th to September 30th, 2026, for its Annual General Meeting scheduled for September 30th, 2026.

16:43 IST BSE
Annual General Meeting

Kabra Drugs Annual General Meeting

Kabra Drugs Ltd shareholders approved a name change and alteration of the MOA object clause via postal ballot. Both resolutions passed with 99.85% votes in favor.

15:25 IST BSE
Annual General Meeting

Kabra Drugs Annual General Meeting

Kabra Drugs Limited published its Postal Ballot Notice in English and Hindi newspapers. This follows the completion of electronic dispatch to shareholders on May 12, 2026.

16:20 IST BSE
Annual General Meeting

Kabra Drugs Annual General Meeting

Kabra Drugs Limited issued a postal ballot notice to shareholders for proposed business resolutions. Voting commences on May 12, 2026, and concludes on June 10, 2026.